High-Efficacy Therapy Discontinuation Vs Continuation in Patients 50 Years and Older with Nonactive MS.
Guillaume Jouvenot, Guilhem Courbon,Mathilde Lefort,Fabien Rollot,Romain Casey,Emmanuelle Le Page,Laure Michel,Gilles Edan,Jerome de Seze,Laurent Kremer,Kevin Bigaut,Sandra Vukusic,Guillaume Mathey,Jonathan Ciron,Aurelie Ruet,Elisabeth Maillart,Pierre Labauge,Helene Zephir,Caroline Papeix,Gilles Defer,Christine Lebrun-Frenay,Thibault Moreau,David Axel Laplaud,Eric Berger,Bruno Stankoff,Pierre Clavelou,Eric Thouvenot,Olivier Heinzlef,Jean Pelletier,Abdullatif Al-Khedr,Olivier Casez,Bertrand Bourre,Philippe Cabre,Abir Wahab,Laurent Magy,Jean-Philippe Camdessanche,Ines Doghri,Solene Moulin, Haifa Ben-Nasr,Celine Labeyrie,Karolina Hankiewicz,Jean-Philippe Neau,Corinne Pottier,Chantal Nifle,Nicolas Collongues,Anne Kerbrat JAMA NEUROLOGY(2024)
AI 理解论文
溯源树
样例